Financial statements Klaster Lifescience Kraków

Balance sheet of Klaster Lifescience Kraków

Company age:
Age:
12 y. 8 m. 3 d.
Profit and loss statement Balance Profitability

Balance sheet data of KLASTER LIFESCIENCE KRAKÓW

Year
2020
2021
2022
2023
Total assets 598 733,51 1 184 071,48 2 398 100,53 1 033 410,40
A. Fixed assets 50 123,31 490 278,37 1 073 953,79 924 336,44
B. Current assets 523 610,20 668 793,11 1 299 146,74 104 073,96
C. Share capital contributions (basic funds) 25 000,00 25 000,00 25 000,00 25 000,00
D. Own shares (stocks) - - - -
Total liabilities 598 733,51 1 184 071,48 2 398 100,53 1 053 410,40
A. Equity 36 160,31 109 621,32 304 435,28 611 285,33
B. Liabilities and provisions for liabilities 562 573,20 1 074 450,16 2 093 665,25 472 125,07
I. Long-term liabilities - - - -
II. Short-term liabilities 132 560,38 80 719,40 100 348,49 42 309,01
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.